carisoprodol

Generic: carisoprodol

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carisoprodol
Generic Name carisoprodol
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carisoprodol 350 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-853
Product ID 76420-853_21e58fc9-d824-4d1d-e063-6294a90a2acc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040792
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2009-08-06

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420853
Hyphenated Format 76420-853

Supplemental Identifiers

RxCUI
197446 730794
UNII
21925K482H
NUI
N0000175730 N0000175737

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carisoprodol (source: ndc)
Generic Name carisoprodol (source: ndc)
Application Number ANDA040792 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 350 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (76420-853-00)
  • 100 TABLET in 1 BOTTLE (76420-853-01)
  • 500 TABLET in 1 BOTTLE (76420-853-05)
  • 30 TABLET in 1 BOTTLE (76420-853-30)
  • 60 TABLET in 1 BOTTLE (76420-853-60)
  • 90 TABLET in 1 BOTTLE (76420-853-90)
source: ndc

Packages (6)

76420-853-00 1000 TABLET in 1 BOTTLE (76420-853-00) 76420-853-01 100 TABLET in 1 BOTTLE (76420-853-01) 76420-853-05 500 TABLET in 1 BOTTLE (76420-853-05) 76420-853-30 30 TABLET in 1 BOTTLE (76420-853-30) 76420-853-60 60 TABLET in 1 BOTTLE (76420-853-60) 76420-853-90 90 TABLET in 1 BOTTLE (76420-853-90)

Ingredients (1)

carisoprodol (350 mg/1)

Linked Drug Pages (1)

carisoprodol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "21e58fc9-d824-4d1d-e063-6294a90a2acc", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["21925K482H"], "rxcui": ["197446", "730794"], "spl_set_id": ["301f5e6a-54e1-4885-b9cb-de475de59b22"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-853-00)", "package_ndc": "76420-853-00", "marketing_start_date": "20240912"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-853-01)", "package_ndc": "76420-853-01", "marketing_start_date": "20240912"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (76420-853-05)", "package_ndc": "76420-853-05", "marketing_start_date": "20240912"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-853-30)", "package_ndc": "76420-853-30", "marketing_start_date": "20240912"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-853-60)", "package_ndc": "76420-853-60", "marketing_start_date": "20240912"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-853-90)", "package_ndc": "76420-853-90", "marketing_start_date": "20240912"}], "brand_name": "carisoprodol", "product_id": "76420-853_21e58fc9-d824-4d1d-e063-6294a90a2acc", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "76420-853", "dea_schedule": "CIV", "generic_name": "carisoprodol", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "350 mg/1"}], "application_number": "ANDA040792", "marketing_category": "ANDA", "marketing_start_date": "20090806", "listing_expiration_date": "20261231"}